Transgene News and Activities

Transgene is owned by Institut Merieux. Institut Merieux has a direct presence in 2 countries.

Institut Merieux has 6 subsidiaries including Advanced BioScience Laboratories, BioMerieux and BioMerieux Americas.

They are in:

• Healthcare43%
• Pharmaceuticals29%
• Other29%

View the org chart displaying its 28 main executives

Most searched biographies at Transgene

• Alessandro Riva, Chairman of the Board and Chief Executive Officer
• Maya Said, Director
• Marie Landel, Director

Create your alert
to follow the executive moves at Transgene.

Institut Merieux has 2,413 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Vertex Pharmaceuticals (United States (USA)).

Popular M&A news in Biotechnology

• Ollin Biosciences has just announced a $330 Million fundraising (posted on June 24 2026).
• RQ Biotechnology has just announced a $86 Million fundraising (posted on June 24 2026).
• Boundless Bio has filed its IPO. Its stock ticker will be AATD. (posted on June 23 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Carl Gordon - Director at Odyssey Therapeutics
• Jan Van de Winkel - President and Chief Executive Officer at Genmab

Learn more about the Biotechnology industry

Press releases by Transgene

• Terms of Use – Transgene
• PME des biotechnologies : comment poursuivre votre développement ? | Euronewseuronews_icons_loading

Social media about Transgene

• Transgene on Wikipedia, Google News & Yahoo Finance
• Transgene on LinkedIn, X (Twitter) & YouTube